Literature DB >> 20945383

Role of Smad2/3 and p38 MAP kinase in TGF-β1-induced epithelial-mesenchymal transition of pulmonary epithelial cells.

Irina Kolosova1, David Nethery, Jeffrey A Kern.   

Abstract

Idiopathic pulmonary fibrosis is characterized by myofibroblast accumulation, extracellular matrix (ECM) remodeling, and excessive collagen deposition. ECM-producing myofibroblasts may originate from epithelial cells through epithelial to mesenchymal transition (EMT). TGF-β1 is an inducer of EMT in pulmonary epithelial cells in vitro and in vivo, though the mechanisms are unclear. We hypothesized that TGF-β1 induced EMT through Smad-dependent and -independent processes. To test this hypothesis, we studied the roles and mechanisms of TGF-β1-induced Smad and p38 mitogen-activated protein kinase (MAPK) signaling in EMT-related changes in pulmonary epithelial cells. Exposure of pulmonary epithelial 1HAEo(-) cells to TGF-β1 resulted in morphological and molecular changes of EMT over a 96-h period; loss of cell-cell contact, cell elongation, down-regulation of E-cadherin, up-regulation of fibronectin, and up-regulation of collagen I. Both Smad2/3 and p38 MAPK signaling pathways were activated by TGF-β1. However, neither Smad2/3 nor p38 MAPK were required for the down-regulation of E-cadherin, yet p38 MAPK was associated with fibronectin up-regulation. Both Smad2/3 and p38 MAPK had a role in regulation of TGF-β1-induced collagen expression. Furthermore, these data demonstrate that Smads and p38 MAPK differentially regulate EMT-related changes in pulmonary epithelial cells.
Copyright © 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 20945383      PMCID: PMC3043117          DOI: 10.1002/jcp.22448

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  50 in total

1.  Reduction of bleomycin induced lung fibrosis by transforming growth factor beta soluble receptor in hamsters.

Authors:  Q Wang; Y Wang; D M Hyde; P J Gotwals; V E Koteliansky; S T Ryan; S N Giri
Journal:  Thorax       Date:  1999-09       Impact factor: 9.139

Review 2.  Epithelial origin of myofibroblasts during fibrosis in the lung.

Authors:  Brigham C Willis; Roland M duBois; Zea Borok
Journal:  Proc Am Thorac Soc       Date:  2006-06

Review 3.  Chemokine/cytokine cocktail in idiopathic pulmonary fibrosis.

Authors:  Carlo Agostini; Carmela Gurrieri
Journal:  Proc Am Thorac Soc       Date:  2006-06

4.  The differential role of Smad2 and Smad3 in the regulation of pro-fibrotic TGFbeta1 responses in human proximal-tubule epithelial cells.

Authors:  Mysore K Phanish; Nadia A Wahab; Paul Colville-Nash; Bruce M Hendry; Mark E C Dockrell
Journal:  Biochem J       Date:  2006-01-15       Impact factor: 3.857

5.  Ubiquitin-dependent degradation of TGF-beta-activated smad2.

Authors:  R S Lo; J Massagué
Journal:  Nat Cell Biol       Date:  1999-12       Impact factor: 28.824

6.  TGF-beta and the Smad signaling pathway support transcriptomic reprogramming during epithelial-mesenchymal cell transition.

Authors:  Ulrich Valcourt; Marcin Kowanetz; Hideki Niimi; Carl-Henrik Heldin; Aristidis Moustakas
Journal:  Mol Biol Cell       Date:  2005-02-02       Impact factor: 4.138

7.  Alveolar epithelial cell mesenchymal transition develops in vivo during pulmonary fibrosis and is regulated by the extracellular matrix.

Authors:  Kevin K Kim; Matthias C Kugler; Paul J Wolters; Liliane Robillard; Michael G Galvez; Alexis N Brumwell; Dean Sheppard; Harold A Chapman
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-21       Impact factor: 11.205

8.  Deletion of Smad2 in mouse liver reveals novel functions in hepatocyte growth and differentiation.

Authors:  Wenjun Ju; Atsushi Ogawa; Joerg Heyer; Dirk Nierhof; Liping Yu; Raju Kucherlapati; David A Shafritz; Erwin P Böttinger
Journal:  Mol Cell Biol       Date:  2006-01       Impact factor: 4.272

Review 9.  Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy.

Authors:  M Selman; T E King; A Pardo
Journal:  Ann Intern Med       Date:  2001-01-16       Impact factor: 25.391

10.  Transforming growth factor-beta1 mediates epithelial to mesenchymal transdifferentiation through a RhoA-dependent mechanism.

Authors:  N A Bhowmick; M Ghiassi; A Bakin; M Aakre; C A Lundquist; M E Engel; C L Arteaga; H L Moses
Journal:  Mol Biol Cell       Date:  2001-01       Impact factor: 4.138

View more
  50 in total

1.  Reactive oxygen species-mediated p38 MAPK regulates carbon nanotube-induced fibrogenic and angiogenic responses.

Authors:  Neelam Azad; Anand Krishnan V Iyer; Liying Wang; Yuxin Liu; Yongju Lu; Yon Rojanasakul
Journal:  Nanotoxicology       Date:  2012-01-20       Impact factor: 5.913

2.  Nitro-oleic acid inhibits vascular endothelial inflammatory responses and the endothelial-mesenchymal transition.

Authors:  Gabriela Ambrozova; Tana Fidlerova; Hana Verescakova; Adolf Koudelka; Tanja K Rudolph; Steven R Woodcock; Bruce A Freeman; Lukas Kubala; Michaela Pekarova
Journal:  Biochim Biophys Acta       Date:  2016-07-16

Review 3.  Notch in fibrosis and as a target of anti-fibrotic therapy.

Authors:  Biao Hu; Sem H Phan
Journal:  Pharmacol Res       Date:  2016-04-21       Impact factor: 7.658

4.  Profibrotic up-regulation of glucose transporter 1 by TGF-β involves activation of MEK and mammalian target of rapamycin complex 2 pathways.

Authors:  Mahefatiana Andrianifahanana; Danielle M Hernandez; Xueqian Yin; Jeong-Han Kang; Mi-Yeon Jung; Youli Wang; Eunhee S Yi; Anja C Roden; Andrew H Limper; Edward B Leof
Journal:  FASEB J       Date:  2016-08-01       Impact factor: 5.191

Review 5.  Transforming Growth Factor β1 Function in Airway Remodeling and Hyperresponsiveness. The Missing Link?

Authors:  Christie A Ojiaku; Edwin J Yoo; Reynold A Panettieri
Journal:  Am J Respir Cell Mol Biol       Date:  2017-04       Impact factor: 6.914

6.  Dasatinib Suppresses TGFβ-Mediated Epithelial-Mesenchymal Transition in Alveolar Epithelial Cells and Inhibits Pulmonary Fibrosis.

Authors:  Ryota Kanemaru; Fumiyuki Takahashi; Motoyasu Kato; Yoichiro Mitsuishi; Ken Tajima; Hiroaki Ihara; Moulid Hidayat; Aditya Wirawan; Yoshika Koinuma; Daisuke Hayakawa; Shigehiro Yagishita; Ryo Ko; Tadashi Sato; Norihiro Harada; Yuzo Kodama; Fariz Nurwidya; Shinichi Sasaki; Shin-Ichiro Niwa; Kazuhisa Takahashi
Journal:  Lung       Date:  2018-06-20       Impact factor: 2.584

7.  Paeoniflorin suppresses TGF-β mediated epithelial-mesenchymal transition in pulmonary fibrosis through a Smad-dependent pathway.

Authors:  Yu Ji; Yan-Nong Dou; Qian-Wen Zhao; Ji-Zhou Zhang; Yan Yang; Ting Wang; Yu-Feng Xia; Yue Dai; Zhi-Feng Wei
Journal:  Acta Pharmacol Sin       Date:  2016-05-02       Impact factor: 6.150

8.  Profibrotic TGFβ responses require the cooperative action of PDGF and ErbB receptor tyrosine kinases.

Authors:  Mahefatiana Andrianifahanana; Mark C Wilkes; Shiv K Gupta; Rod A Rahimi; Claire E Repellin; Maryanne Edens; Joshua Wittenberger; Xueqian Yin; Elizabeth Maidl; Jackson Becker; Edward B Leof
Journal:  FASEB J       Date:  2013-08-02       Impact factor: 5.191

Review 9.  Signaling pathway cooperation in TGF-β-induced epithelial-mesenchymal transition.

Authors:  Rik Derynck; Baby Periyanayaki Muthusamy; Koy Y Saeteurn
Journal:  Curr Opin Cell Biol       Date:  2014-09-18       Impact factor: 8.382

10.  The plant alkaloid conophylline inhibits matrix formation of fibroblasts.

Authors:  Takehiko Tezuka; Akinobu Ota; Sivasundaram Karnan; Katsuhiko Matsuura; Kazuhisa Yokoo; Yoshitaka Hosokawa; Davide Vigetti; Alberto Passi; Sonoko Hatano; Kazuo Umezawa; Hideto Watanabe
Journal:  J Biol Chem       Date:  2018-10-30       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.